Related by context. Frequent words. (Click for all words.) 56 confirmatory Phase III 53 Investigational Device Exemption IDE 53 tezampanel 52 Phenoptin 52 Complete Response 52 Phase 2b study 52 Vilazodone 52 Approvable Letter 52 confirmatory Phase 3 52 MOZOBIL 52 Board DSMB 51 Menerba 51 APF# 51 NDA submission 51 Scientific Advice 51 orphan designation 51 FavId 51 PS# [001] 50 maribavir 50 IND enabling 50 PDUFA date 50 QRxPharma 50 teduglutide 50 orBec R 50 Serdaxin 50 palifosfamide 50 clinical endpoints 50 Phase 2a clinical 50 alogliptin 50 ONCONASE 50 Phase III pivotal 49 Phase 1b trial 49 Phase 2a trial 49 BENLYSTA 49 DAVANAT R 49 phase 2a 49 oritavancin 49 ATryn R 49 Marketing Authorization Application 49 SILENOR TM 49 methylnaltrexone 49 Phase 1b clinical 49 phase IIb 49 fidaxomicin 49 stockholder approvals 48 DAVANAT ® 48 Biologics License Application BLA 48 Amigal 48 Phase IIa trial 48 Phase III clinical 48 Marqibo 48 MBP# [001] 48 HspE7 48 risks anduncertainties 48 investigational 48 Restanza 48 StaphVAX 48 disinterested shareholder 48 clinical trial 48 CHMP opinion 48 Phase IIa clinical 48 Bronchitol 48 Dyloject 47 SFDA approval 47 Phase 2a 47 Fast Track designation 47 INCB# [002] 47 Rhucin ® 47 diabetic neuropathic pain 47 pivotal Phase III 47 voclosporin 47 phase IIa 47 Phase Ib 47 NexACT 47 bafetinib 47 Biologics License Application 47 Gestiva 47 Iluvien 47 Intermezzo R 47 Phase 2b clinical 47 Phase IIb clinical 47 Arpida 47 oral formulation 47 Fast Track Designation 46 Phase 2b 46 Phase 2b trial 46 AP# [003] 46 clinical trials 46 Santhera 46 sBLA 46 VQD 46 Promacta 46 Indiplon 46 Topical Interferon Alpha 2b 46 pivotal Phase 46 Tranzyme Pharma 46 investigational compound 45 Investigational 45 efficacy endpoints 45 Mozobil 45 INDs